查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782950

全球神经科技设备市场

Neurotech Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 296 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计 2030 年全球神经科技设备市场规模将达 303 亿美元

全球神经技术设备市场规模预计在2024年达到152亿美元，预计在分析期（2024-2030年）内将以12.2%的复合年增长率增长，到2030年将达到303亿美元。神经刺激是本报告分析的细分市场之一，预计其复合年增长率将达到10.4%，到分析期结束时达到124亿美元。神经假体细分市场在分析期间的复合年增长率预计为14.9%。

美国市场规模估计为 41 亿美元，中国市场预计复合年增长率为 16.1%

预计2024年，美国神经科技设备市场规模将达41亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到63亿美元，在2024-2030年的分析期间内，复合年增长率将达到16.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为9.1%和10.7%。在欧洲，预计德国市场的复合年增长率约为9.6%。

全球神经科技设备市场—主要趋势与驱动因素摘要

神经技术设备如何彻底改变脑机互动和神经健康？

神经技术设备正在改变人类与科技的互动方式，实现脑机介面 (BCI)、神经刺激疗法、认知增强和即时神经监测。这些设备弥合了神经科学与数位技术之间的差距，为癫痫、忧郁症、帕金森氏症和脊髓损伤等疾病提供了突破性的解决方案。脑植入、穿戴式神经刺激设备和基于非侵入性脑电图的系统使人们能够恢復运动矫正器具义肢使用神经讯号进行交流。神经技术在心理健康治疗中也发挥着重要作用，经颅磁刺激 (TMS) 和迷走神经刺激 (VNS) 正在成为抗治疗性忧郁症和焦虑症的有效治疗方法。神经回馈设备在认知训练、注意力改善和压力管理方面的应用日益广泛，进一步扩展了神经技术的范围。人工智慧 (AI) 和机器学习的进步使得即时神经数据分析成为可能，为精准神经治疗铺平了道路。随着全球人口老化和神经退化性疾病日益普遍，神经技术设备越来越多地被融入主流医疗保健，以透过直接的脑机互动来增强神经復健并拓展人类潜能。

哪些挑战阻碍了神经技术设备的普及？

儘管神经科技设备发展迅速，仍面临许多挑战，阻碍其广泛应用。其中一个主要障碍是开发和部署成本高昂，尤其是植入式脑机介面 (BCI) 和先进的神经调节疗法。围绕脑机介面和神经刺激技术的伦理和监管问题也构成了另一个障碍，因为长期安全性、隐私以及神经资料的潜在滥用仍然是亟待解决的问题。解读脑波讯号的复杂性和患者反应的多变性也对神经科技应用的可靠性和有效性提出了挑战。许多神经科技设备需要强大的运算能力和即时处理能力，这引发了人们对能耗和设备小型化的担忧。此外，人们对侵入式脑植入的质疑以及对连网神经科技解决方案资料安全性的担忧，正在减缓其应用速度。各种神经科技平台之间的标准化以及与现有医疗保健系统的互通性方面仍存在一些尚未解决的问题，这使得将其整合到临床工作流程中更具挑战性。应对这些挑战需要加强对神经伦理学的投入，促进神经科学家和工程师之间的跨学科合作，并开发低功耗无线神经科技解决方案，以提高使用者的可及性和安全性。

哪些创新正在突破神经科技的界限？

神经科技市场正经历快速的技术创新，新技术不断提升脑机介面和神经调节设备的功能性、准确性和可近性。高密度柔性神经植入的开发改进了脑波讯号采集，并扩展了设备性能。人工智慧驱动的脑机介面 (BCI) 能够更快、更准确地解码神经活动，为直接控制思维的装置打开了大门。功能性近红外线光谱 (fNIRS) 和干电极脑电图耳机等非侵入式神经技术解决方案的兴起，使得神经技术更容易应用于消费性应用，包括游戏、生产力和冥想。神经刺激技术也不断发展，闭合迴路回馈系统可以根据即时脑活动自动调整刺激参数，从而提高其对癫痫和慢性疼痛等疾病的疗效。无线神经技术的进步实现了脑感测器和外部设备之间的无缝连接，减少了对侵入性手术的需求。此外，神经技术与扩增实境(AR) 和虚拟实境 (VR) 的融合，正在为认知疗法、疼痛管理和神经復健领域开启新的可能性。随着科技创新的加速，神经科技正变得更加复杂、个人化，并日益融入日常生活，进而改变人机互动的未来。

是什么推动了神经技术设备市场的成长？

神经技术设备市场的成长受到多种因素的推动，包括神经系统疾病盛行率的上升、对脑机介面研究的投入增加以及消费者对认知增强技术日益增长的兴趣。随着非侵入性植入式装置获得 FDA核准用于治疗癫痫、忧郁症和帕金森氏症等疾病，对神经刺激疗法的需求正在激增。人工智慧主导的脑机介面的扩展进一步推动了市场成长，公司正在开发意念控制的义肢、辅助通讯工具和免持运算解决方案。穿戴式神经技术在健康和心理健康领域的应用日益广泛，例如用于改善睡眠和减轻压力的神经回馈设备，正在将市场扩展到临床应用之外。对个人化医疗和即时脑监测的推动正在推动对下一代脑电图和神经成像成像技术的投资，从而提高神经系统诊断的准确性。此外，支持神经技术研究的政府倡议，如美国脑倡议和欧洲人脑计划，正在刺激创新和商业化。随着神经技术设备的不断发展，其应用将扩展到医疗保健、消费技术、国防和人类增强，并有望在未来几年实现快速的市场成长。

部分

产品类型（神经刺激、神经修復、神经感测、神经復健）、病情类型（巴金森氏症、疼痛管理、认知障碍、癫痫、尿失禁和大便失禁、听力障碍、忧郁症、睡眠障碍）

受访公司范例

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP32330

Global Neurotech Devices Market to Reach US$30.3 Billion by 2030

The global market for Neurotech Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$30.3 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Neurostimulation, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Neuroprostheses segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 16.1% CAGR

The Neurotech Devices market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Neurotech Devices Market - Key Trends & Drivers Summarized

How Are Neurotech Devices Revolutionizing Brain-Computer Interaction and Neural Health?

Neurotech devices are transforming the way humans interact with technology, enabling brain-computer interfaces (BCIs), neurostimulation therapies, cognitive enhancement, and real-time neurological monitoring. These devices bridge the gap between neuroscience and digital technology, offering groundbreaking solutions for conditions such as epilepsy, depression, Parkinson’s disease, and spinal cord injuries. Brain implants, wearable neurostimulation devices, and non-invasive EEG-based systems are enabling individuals to regain mobility, control prosthetics, and communicate using neural signals. Neurotech is also playing a crucial role in mental health treatment, with transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS) emerging as effective therapies for treatment-resistant depression and anxiety disorders. The growing adoption of neurofeedback devices for cognitive training, focus improvement, and stress management is further expanding the neurotech landscape. Advances in artificial intelligence (AI) and machine learning are enabling real-time neural data analysis, paving the way for precision neurotherapies. As the global population ages and neurodegenerative disorders become more prevalent, neurotech devices are increasingly being integrated into mainstream healthcare, enhancing neurological rehabilitation and expanding human potential through direct brain-machine interaction.

What Challenges Are Slowing the Adoption of Neurotech Devices?

Despite rapid advancements, neurotech devices face several challenges that hinder widespread adoption. One of the key obstacles is the high cost of development and implementation, particularly for implantable BCIs and advanced neuromodulation therapies. Ethical and regulatory concerns surrounding brain-computer interfaces and neurostimulation technologies pose additional hurdles, as long-term safety, privacy, and potential misuse of neurodata remain pressing concerns. The complexity of brain signal interpretation and variability in patient responses also challenge the reliability and effectiveness of neurotech applications. Many neurotech devices require significant computational power and real-time processing capabilities, leading to concerns about energy consumption and device miniaturization. Additionally, public skepticism regarding invasive brain implants and concerns over data security in connected neurotech solutions slow adoption rates. Standardization across different neurotech platforms and interoperability with existing healthcare systems remain unresolved issues, making integration into clinical workflows more difficult. Addressing these challenges requires increased investment in neuroethics, cross-disciplinary collaboration between neuroscientists and engineers, and advancements in low-power, wireless neurotech solutions that improve user accessibility and safety.

How Are Innovations Pushing the Boundaries of Neurotech?

The neurotech market is undergoing rapid innovation, with new technologies enhancing the functionality, accuracy, and accessibility of brain-machine interfaces and neuromodulation devices. The development of high-density, flexible neural implants is allowing for improved brain signal acquisition and longer-lasting device performance. AI-powered BCIs are enabling faster and more accurate decoding of neural activity, opening doors for direct thought-controlled devices. The rise of non-invasive neurotech solutions, such as functional near-infrared spectroscopy (fNIRS) and dry-electrode EEG headsets, is making neurotechnology more accessible for consumer applications, including gaming, productivity enhancement, and meditation. Neurostimulation is also evolving, with closed-loop feedback systems that automatically adjust stimulation parameters based on real-time brain activity, improving efficacy for conditions such as epilepsy and chronic pain. Advances in wireless neurotech are enabling seamless connectivity between brain sensors and external devices, reducing the need for invasive procedures. Additionally, the convergence of neurotech with augmented reality (AR) and virtual reality (VR) is opening new possibilities in cognitive therapy, pain management, and neurorehabilitation. As innovation accelerates, neurotech is becoming more sophisticated, personalized, and integrated into everyday life, transforming the future of human-computer interaction.

What Is Driving the Growth of the Neurotech Devices Market?

The growth in the neurotech devices market is driven by several factors, including the increasing prevalence of neurological disorders, rising investments in brain-machine interface research, and growing consumer interest in cognitive enhancement technologies. The demand for neurostimulation therapies is surging as non-invasive and implantable devices gain FDA approvals for conditions such as epilepsy, depression, and Parkinson’s disease. The expansion of AI-driven brain-computer interfaces is further fueling market growth, with companies developing mind-controlled prosthetics, assistive communication tools, and hands-free computing solutions. The growing adoption of wearable neurotech in wellness and mental health, including neurofeedback devices for sleep improvement and stress reduction, is expanding the market beyond clinical applications. The push for personalized medicine and real-time brain monitoring is driving investment in next-generation EEG and neuroimaging technologies, enhancing the precision of neurological diagnostics. Additionally, government initiatives supporting neurotechnology research, such as the U.S. BRAIN Initiative and the European Human Brain Project, are fostering innovation and commercialization. As neurotech devices continue to evolve, their applications are expanding across healthcare, consumer technology, defense, and human augmentation, positioning the market for rapid growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Neurotech Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation); Condition Type (Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy, Urinary & Fecal Incontinence, Hearing Conditions, Depression, Sleep Disorders)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurotech Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Neurological Disorders Spurs Demand for Advanced Neurotech Solutions
    • Rising Investment in Brain-Computer Interface (BCI) Research Expands Addressable Market Opportunity
    • Increasing Integration of AI and Machine Learning in Neurotech Devices Strengthens Business Case for Adoption
    • Heightened Consumer Interest in Cognitive Enhancement Technologies Drives Demand for Wearable Neurotech
    • Surge in Mental Health Awareness Throws the Spotlight on Non-Invasive Neuromodulation Therapies
    • Rapid Advancements in Miniaturization and Implantable Device Technology Propel Growth in Medical Neurodevices
    • Adoption of Personalized Neurological Therapies Accelerates Demand for Patient-Centric Neurotech Solutions
    • Favorable Regulatory Approvals for Novel Neurostimulation Devices Sustain Growth Momentum
    • Rise in Telehealth and Remote Monitoring Trends Drives Adoption of Connected Neurotech Platforms
    • Growing Use of Neurotech Devices in Rehabilitation and Stroke Recovery Expands Clinical Application Scope
    • Increasing Demand for Non-Pharmacological Treatment Alternatives Generates Opportunity for Neurotherapy Devices
    • Military and Defense Interest in Cognitive Augmentation Technologies Opens Up New Strategic Market Frontiers
    • Aging Global Population and Increasing Incidence of Neurodegenerative Diseases Drive Device Penetration
    • Integration of Cloud and Big Data Analytics in Neurological Monitoring Enhances Market Attractiveness
    • Venture Capital and Strategic Partnerships in Neurotech Innovation Accelerate Market Commercialization
    • Emergence of Consumer Neurotech in Wellness and Gaming Sectors Drives Market Diversification
    • High Cost of R&D and Commercialization Challenges Present Barriers to Entry for Emerging Players
    • Growing Use of EEG and Neuroimaging in Brain Research Spurs Demand for Advanced Diagnostic Tools
    • Evolving Regulatory Landscape and Reimbursement Policies Shape Market Dynamics and Access
    • Increasing Cross-Disciplinary Collaboration in Neuroscience, Engineering, and Data Science Fuels Innovation Pipeline
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurotech Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neuroprostheses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Neurosensing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Neurorehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hearing Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Sleep Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CHINA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • INDIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030

IV. COMPETITION